[go: up one dir, main page]

WO2010004562A3 - Methods and compositions for detecting colorectal cancer - Google Patents

Methods and compositions for detecting colorectal cancer Download PDF

Info

Publication number
WO2010004562A3
WO2010004562A3 PCT/IL2009/000683 IL2009000683W WO2010004562A3 WO 2010004562 A3 WO2010004562 A3 WO 2010004562A3 IL 2009000683 W IL2009000683 W IL 2009000683W WO 2010004562 A3 WO2010004562 A3 WO 2010004562A3
Authority
WO
WIPO (PCT)
Prior art keywords
colorectal cancer
compositions
methods
detecting colorectal
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2009/000683
Other languages
French (fr)
Other versions
WO2010004562A2 (en
Inventor
Baruch Brenner
Shlomit Gilad
Yaron Goren
Ayelet Chajut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mor Research Applications Ltd
Rosetta Genomics Ltd
Original Assignee
Mor Research Applications Ltd
Rosetta Genomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applications Ltd, Rosetta Genomics Ltd filed Critical Mor Research Applications Ltd
Publication of WO2010004562A2 publication Critical patent/WO2010004562A2/en
Publication of WO2010004562A3 publication Critical patent/WO2010004562A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a method for conducting minimally-invasive early detection of colorectal cancer and/or of colorectal cancer precursor cells, by using microRNA molecules associated with colorectal cancer, as well as various nucleic acid molecules relating thereto or derived thereof.
PCT/IL2009/000683 2008-07-09 2009-07-08 Methods and compositions for detecting colorectal cancer Ceased WO2010004562A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7913608P 2008-07-09 2008-07-09
US61/079,136 2008-07-09

Publications (2)

Publication Number Publication Date
WO2010004562A2 WO2010004562A2 (en) 2010-01-14
WO2010004562A3 true WO2010004562A3 (en) 2010-04-01

Family

ID=41204073

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2009/000683 Ceased WO2010004562A2 (en) 2008-07-09 2009-07-08 Methods and compositions for detecting colorectal cancer

Country Status (1)

Country Link
WO (1) WO2010004562A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2762986C (en) 2009-05-22 2018-03-06 Asuragen, Inc. Mirna biomarkers of prostate disease
US8735074B2 (en) 2009-08-28 2014-05-27 Asuragen, Inc. MiRNA biomarkers of lung disease
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
CN103384829A (en) * 2011-01-13 2013-11-06 财团法人工业技术研究院 Biomarkers for predicting recurrence of colorectal cancer
NO3051026T3 (en) 2011-10-21 2018-07-28
WO2016034715A2 (en) * 2014-09-05 2016-03-10 Prestizia Method for predicting the development of colorectal cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009008720A2 (en) * 2007-07-06 2009-01-15 Koninklijke Nederlandse Akademie Van Wetenschappen Small rna molecules, precursors thereof, means and methods for detecting them, and uses thereof in typing samples
WO2009025852A2 (en) * 2007-08-22 2009-02-26 Xenomics, Inc. Methods of using mirna for detection of in vivo cell death
WO2009057113A2 (en) * 2007-10-31 2009-05-07 Rosetta Genomics Ltd. Diagnosis and prognosis of specific cancers by means of differential detection of micro-rnas/mirnas

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009008720A2 (en) * 2007-07-06 2009-01-15 Koninklijke Nederlandse Akademie Van Wetenschappen Small rna molecules, precursors thereof, means and methods for detecting them, and uses thereof in typing samples
WO2009025852A2 (en) * 2007-08-22 2009-02-26 Xenomics, Inc. Methods of using mirna for detection of in vivo cell death
WO2009057113A2 (en) * 2007-10-31 2009-05-07 Rosetta Genomics Ltd. Diagnosis and prognosis of specific cancers by means of differential detection of micro-rnas/mirnas

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BANDRÉS E ET AL: "Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 5, no. 1, 19 July 2006 (2006-07-19), pages 29, XP021018291, ISSN: 1476-4598 *
CHAJUT AYELET ET AL: "MicroRNA profiles in body fluids as a novel class of biomarkers.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 49, April 2008 (2008-04-01), & 99TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH; SAN DIEGO, CA, USA; APRIL 12 -16, 2008, pages 1231, XP008107302, ISSN: 0197-016X *
CHEN XI ET AL: "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", CELL RESEARCH, vol. 18, no. 10, October 2008 (2008-10-01), pages 997 - 1006, XP002552942, ISSN: 1001-0602 *
LAWRIE CHARLES H ET AL: "Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma", BRITISH JOURNAL OF HAEMATOLOGY, BLACKWELL PUBLISHING LTD, vol. 141, no. 5, 1 May 2008 (2008-05-01), pages 672 - 675, XP002518103, ISSN: 1365-2141, [retrieved on 20080303] *
MITCHELL PATRICK S ET AL: "Circulating microRNAs as stable blood-based markers for cancer detection", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,, vol. 105, no. 30, 29 July 2008 (2008-07-29), pages 10513 - 10518, XP002545745 *
NAKAJIMA GO ET AL: "NON-CODING MICRORNAS HSA-LET-7G AND HSA-MIR-181B ARE ASSOCIATED WITH CHEMORESPONSE TO S-1 IN COLON CANCER", CANCER GENOMICS AND PROTEOMICS, XX, vol. 3, no. 5, 1 September 2006 (2006-09-01), pages 317 - 324, XP008075172, ISSN: 1109-6535 *
SUNG J J ET AL: "1070 Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer Screening", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 136, no. 5, 1 May 2009 (2009-05-01), pages A - 165, XP026111290, ISSN: 0016-5085, [retrieved on 20090501] *
XI Y ET AL: "Prognostic Values of microRNAs in Colorectal Cancer", BIOMARKER INSIGHTS, LIBERTAS ACADEMICA LTD, NEW ZEALAND, vol. 2, 7 February 2007 (2007-02-07), pages 113 - 121, XP002512901, ISSN: 1177-2719, Retrieved from the Internet <URL:http://www.la-press.com/prognostic-values-of-micrornas-in-colorectal- cancer-a23> [retrieved on 20060101] *

Also Published As

Publication number Publication date
WO2010004562A2 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
WO2010018563A3 (en) Compositions and methods for the prognosis of lymphoma
WO2010127304A3 (en) Sequencing methods
EP2129797B8 (en) Nucleic acid detection
WO2010019414A3 (en) Detecting nucleic acid
WO2009153775A3 (en) Methods for distinguishing between specific types of lung cancers
GB0713143D0 (en) Nucleic acid detection method
EP2294225B8 (en) Method for direct amplification from crude nucleic acid samples
WO2014182528A3 (en) Multiplex labeling of molecules by sequential hybridization barcoding
SI2089343T1 (en) Click chemistry for the production of reporter molecules
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2009120374A3 (en) Methods and compositions for nucleic acid sample preparation
EP2746395A4 (en) Primer set, method for amplifying target nucleic acid sequence using same, and method for detecting mutated nucleic acid using same
WO2009124255A8 (en) Methods for transcript analysis
WO2009113828A3 (en) Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
WO2009135218A3 (en) Detecting genetic predisposition to osteoarthritis associated conditions
WO2012012725A3 (en) Methods of detecting diseases or conditions using phagocytic cells
WO2008087040A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
WO2008067423A3 (en) Methods of improving the introduction of dna into bacterial cells
WO2009102569A3 (en) Cell lines and methods for making and using them
EP2354226A4 (en) Method for detecting controls for nucleic acid amplification, and use thereof
WO2011030313A3 (en) A method for detecting an analyte
WO2010004562A3 (en) Methods and compositions for detecting colorectal cancer
EP2208795A4 (en) Nucleic acid detection method, and nucleic acid detection kit
WO2012034130A3 (en) Methods and compositions for nucleic acid detection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09787462

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09787462

Country of ref document: EP

Kind code of ref document: A2